These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 625290)

  • 21. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 22. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 24. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR; Appel SH
    Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR): the significance in myasthenia gravis (MG)].
    Shibuya N; Kanazawa H; Uyemura K
    Rinsho Shinkeigaku; 1988 Mar; 28(3):315-9. PubMed ID: 3402139
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
    Nishitani H; Noguchi S; Ohta K; Matsubara S
    No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
    [No Abstract]   [Full Text] [Related]  

  • 30. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.
    Lefvert AK
    Clin Exp Immunol; 1978 Oct; 34(1):111-7. PubMed ID: 750115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
    Lefvert AK
    Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum.
    Harvey AL; Robertson JG; Barkas T; Harrison R; Lunt GG; Stephenson FA; Campbell MJ; Teague RH
    Clin Exp Immunol; 1978 Dec; 34(3):411-6. PubMed ID: 743809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies not directed against the acetylcholine receptor in myasthenia gravis. An immunoblot study.
    Zimmermann CW; Weiss G
    J Neuroimmunol; 1987 Oct; 16(2):225-36. PubMed ID: 3624455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
    Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR
    Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

  • 39. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.